Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
61 participants
OBSERVATIONAL
2021-09-15
2023-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Serum Sclerostin Levels in Cholesteatoma Patients
NCT03954288
Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut
NCT07157189
A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
NCT06145893
Ozone Therapy in Ankylosing Spondylitis
NCT05429801
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
NCT06894602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Psoriasis
They will undergo dermatological assessment and a blinded ultrasound (US) evaluation.
Ultrasound
Evaluation consisted of the detection of grey scale (GS) enthesitis and Power Doppler signal in enthesis areas of participants. The Madrid Sonography Enthesitis Index (MASEI) scoring system was used to quantify the extent of sonographic entheseal abnormalities
Control
They will also undergo dermatological assessment and a blinded ultrasound (US) evaluation.
Ultrasound
Evaluation consisted of the detection of grey scale (GS) enthesitis and Power Doppler signal in enthesis areas of participants. The Madrid Sonography Enthesitis Index (MASEI) scoring system was used to quantify the extent of sonographic entheseal abnormalities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound
Evaluation consisted of the detection of grey scale (GS) enthesitis and Power Doppler signal in enthesis areas of participants. The Madrid Sonography Enthesitis Index (MASEI) scoring system was used to quantify the extent of sonographic entheseal abnormalities
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with psoriasis without musculoskeletal symptoms
* Healthy controls
* No joint involvement and no clinical symptoms and signs of enthesitis and synovitis
Exclusion Criteria
* Have history of trauma and intensive sport activity in last 2 weeks.
* Have received any systemic therapy (i.e. DMARD, NSAIDs, corticosteroids, immunosuppressants, retinoids or biological agents) in 3 months
* Pregnant or breast-feeding
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fatih Sultan Mehmet Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Duygu Karamanlıoğlu
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Duygu Silte Karamanlioglu, MD
Role: PRINCIPAL_INVESTIGATOR
Fatih Sultan Mehmet Training and Research Hospital
Feyza Unlu Ozkan, Prof.
Role: STUDY_CHAIR
Fatih Sultan Mehmet Training and Research Hospital
Eylem Ceren Arikan, MD
Role: STUDY_CHAIR
Fatih Sultan Mehmet Training and Research Hospital
Betül Zehra Pirdal, MD
Role: STUDY_CHAIR
Istanbul Sultangazi District Health Directorate
Gulcan Ozturk, MD
Role: STUDY_CHAIR
Fatih Sultan Mehmet Training and Research Hospital
Ilknur Aktas, Prof
Role: STUDY_DIRECTOR
Fatih Sultan Mehmet Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fatih Sultan Mehmet Training and Research Hospital
Istanbul, Atasehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
karamanlioglu.duygu
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.